Last updated on February 2019

Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program


Brief description of study

The primary objective of this study is to establish a control population to assess performance of an investigational diagnostic test targeting lung neoplasms.

Detailed Study Description

Subjects will be participating in a lung cancer screening program at enrollment. Subjects will have a blood sample collected within 60 days of a low-dose CT scan (LDCT). Subjects with nodules present on the LDCT or subjects with a clean LDCT scheduled for a 12-month follow-up may have another blood draw at 12 months.

Clinical Study Identifier: NCT03628638

Contact Investigators or Research Sites near you

Start Over

Meritus Center for Clinical Research

Hagerstown, MD United States
2.97miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.